調査レポート | • レポートコード：QYR2104Z2499 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、胃腸のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（処方胃腸薬、OTC胃腸薬）、用途別市場規模（慢性胃炎、機能性消化不良、消化性潰瘍、急性胃腸炎、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・胃腸の市場動向 ・企業の競争状況、市場シェア ・胃腸の種類別市場規模（処方胃腸薬、OTC胃腸薬） ・胃腸の用途別市場規模（慢性胃炎、機能性消化不良、消化性潰瘍、急性胃腸炎、その他） ・胃腸の北米市場規模2016-2027（アメリカ、カナダ） ・胃腸のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・胃腸のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・胃腸の中南米市場規模2016-2027（メキシコ、ブラジル） ・胃腸の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZenec、Sanofi、Bayer、Pfizer、GlaxoSmithKline、Teva、Zeria（Tillotts）、Perrigo、Boehringer Ingelheim、Purdue Pharma、C.B. Fleet、Abbott、Jiangzhong、Xian-Janssen） ・結論 |
Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn’s disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
The global average gross margin of Gastrointestinal is in a slight decreasing trend, and the gross margin is 63% in 2015.
Europe region is the largest supplier of Gastrointestinal, with a production revenue market share nearly 50% in 2015. North America is the second largest supplier of Gastrointestinal, enjoying production revenue market share nearly 22% in 2015.
North America is the largest consumption place, with a consumption value market share nearly 52% in 2015. Following North America, Europe is the second largest consumption place with the consumption value market share of 22% in 2015.
Market competition is intense. AstraZeneca, Sanofi, Bayer, Pfizer, GlaxoSmithKline, etc. are the leaders of the industry, and they hold high-end customers, and their products are famous in the world.
With the development of economic, more and more companies participate in this industry with their new type products.
Market Analysis and Insights: Global Gastrointestinal Market
The global Gastrointestinal market size is projected to reach US$ 36120 million by 2026, from US$ 34140 million in 2019, at a CAGR of 0.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Gastrointestinal market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Gastrointestinal market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Gastrointestinal market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Gastrointestinal market.
Global Gastrointestinal Scope and Market Size
Gastrointestinal market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Gastrointestinal market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Prescription Gastrointestinal Drug
OTC Gastrointestinal Drug
Segment by Application
Chronic Gastritis
Functional Dyspepsia
Peptic Ulcer
Acute Gastroenteritis
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZenec
Sanofi
Bayer
Pfizer
GlaxoSmithKline
Teva
Zeria（Tillotts）
Perrigo
Boehringer Ingelheim
Pfizer
GlaxoSmithKline
Abbott
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gastrointestinal Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Prescription Gastrointestinal Drug
1.2.3 OTC Gastrointestinal Drug
1.3 Market by Application
1.3.1 Global Gastrointestinal Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Chronic Gastritis
1.3.3 Functional Dyspepsia
1.3.4 Peptic Ulcer
1.3.5 Acute Gastroenteritis
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Gastrointestinal Market Perspective (2016-2027)
2.2 Gastrointestinal Growth Trends by Regions
2.2.1 Gastrointestinal Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastrointestinal Historic Market Share by Regions (2016-2021)
2.2.3 Gastrointestinal Forecasted Market Size by Regions (2022-2027)
2.3 Gastrointestinal Industry Dynamic
2.3.1 Gastrointestinal Market Trends
2.3.2 Gastrointestinal Market Drivers
2.3.3 Gastrointestinal Market Challenges
2.3.4 Gastrointestinal Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gastrointestinal Players by Revenue
3.1.1 Global Top Gastrointestinal Players by Revenue (2016-2021)
3.1.2 Global Gastrointestinal Revenue Market Share by Players (2016-2021)
3.2 Global Gastrointestinal Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Gastrointestinal Revenue
3.4 Global Gastrointestinal Market Concentration Ratio
3.4.1 Global Gastrointestinal Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Revenue in 2020
3.5 Gastrointestinal Key Players Head office and Area Served
3.6 Key Players Gastrointestinal Product Solution and Service
3.7 Date of Enter into Gastrointestinal Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gastrointestinal Breakdown Data by Type
4.1 Global Gastrointestinal Historic Market Size by Type (2016-2021)
4.2 Global Gastrointestinal Forecasted Market Size by Type (2022-2027)
5 Gastrointestinal Breakdown Data by Application
5.1 Global Gastrointestinal Historic Market Size by Application (2016-2021)
5.2 Global Gastrointestinal Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Gastrointestinal Market Size (2016-2027)
6.2 North America Gastrointestinal Market Size by Type
6.2.1 North America Gastrointestinal Market Size by Type (2016-2021)
6.2.2 North America Gastrointestinal Market Size by Type (2022-2027)
6.2.3 North America Gastrointestinal Market Size by Type (2016-2027)
6.3 North America Gastrointestinal Market Size by Application
6.3.1 North America Gastrointestinal Market Size by Application (2016-2021)
6.3.2 North America Gastrointestinal Market Size by Application (2022-2027)
6.3.3 North America Gastrointestinal Market Size by Application (2016-2027)
6.4 North America Gastrointestinal Market Size by Country
6.4.1 North America Gastrointestinal Market Size by Country (2016-2021)
6.4.2 North America Gastrointestinal Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Gastrointestinal Market Size (2016-2027)
7.2 Europe Gastrointestinal Market Size by Type
7.2.1 Europe Gastrointestinal Market Size by Type (2016-2021)
7.2.2 Europe Gastrointestinal Market Size by Type (2022-2027)
7.2.3 Europe Gastrointestinal Market Size by Type (2016-2027)
7.3 Europe Gastrointestinal Market Size by Application
7.3.1 Europe Gastrointestinal Market Size by Application (2016-2021)
7.3.2 Europe Gastrointestinal Market Size by Application (2022-2027)
7.3.3 Europe Gastrointestinal Market Size by Application (2016-2027)
7.4 Europe Gastrointestinal Market Size by Country
7.4.1 Europe Gastrointestinal Market Size by Country (2016-2021)
7.4.2 Europe Gastrointestinal Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Gastrointestinal Market Size (2016-2027)
8.2 Asia-Pacific Gastrointestinal Market Size by Type
8.2.1 Asia-Pacific Gastrointestinal Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Gastrointestinal Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Gastrointestinal Market Size by Type (2016-2027)
8.3 Asia-Pacific Gastrointestinal Market Size by Application
8.3.1 Asia-Pacific Gastrointestinal Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Gastrointestinal Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Gastrointestinal Market Size by Application (2016-2027)
8.4 Asia-Pacific Gastrointestinal Market Size by Region
8.4.1 Asia-Pacific Gastrointestinal Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Gastrointestinal Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Gastrointestinal Market Size (2016-2027)
9.2 Latin America Gastrointestinal Market Size by Type
9.2.1 Latin America Gastrointestinal Market Size by Type (2016-2021)
9.2.2 Latin America Gastrointestinal Market Size by Type (2022-2027)
9.2.3 Latin America Gastrointestinal Market Size by Type (2016-2027)
9.3 Latin America Gastrointestinal Market Size by Application
9.3.1 Latin America Gastrointestinal Market Size by Application (2016-2021)
9.3.2 Latin America Gastrointestinal Market Size by Application (2022-2027)
9.3.3 Latin America Gastrointestinal Market Size by Application (2016-2027)
9.4 Latin America Gastrointestinal Market Size by Country
9.4.1 Latin America Gastrointestinal Market Size by Country (2016-2021)
9.4.2 Latin America Gastrointestinal Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gastrointestinal Market Size (2016-2027)
10.2 Middle East & Africa Gastrointestinal Market Size by Type
10.2.1 Middle East & Africa Gastrointestinal Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Gastrointestinal Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Gastrointestinal Market Size by Type (2016-2027)
10.3 Middle East & Africa Gastrointestinal Market Size by Application
10.3.1 Middle East & Africa Gastrointestinal Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Gastrointestinal Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Gastrointestinal Market Size by Application (2016-2027)
10.4 Middle East & Africa Gastrointestinal Market Size by Country
10.4.1 Middle East & Africa Gastrointestinal Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Gastrointestinal Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZenec
11.1.1 AstraZenec Company Details
11.1.2 AstraZenec Business Overview
11.1.3 AstraZenec Gastrointestinal Introduction
11.1.4 AstraZenec Revenue in Gastrointestinal Business (2016-2021)
11.1.5 AstraZenec Recent Development
11.2 Sanofi
11.2.1 Sanofi Company Details
11.2.2 Sanofi Business Overview
11.2.3 Sanofi Gastrointestinal Introduction
11.2.4 Sanofi Revenue in Gastrointestinal Business (2016-2021)
11.2.5 Sanofi Recent Development
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Gastrointestinal Introduction
11.3.4 Bayer Revenue in Gastrointestinal Business (2016-2021)
11.3.5 Bayer Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Gastrointestinal Introduction
11.4.4 Pfizer Revenue in Gastrointestinal Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Gastrointestinal Introduction
11.5.4 GlaxoSmithKline Revenue in Gastrointestinal Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Teva
11.6.1 Teva Company Details
11.6.2 Teva Business Overview
11.6.3 Teva Gastrointestinal Introduction
11.6.4 Teva Revenue in Gastrointestinal Business (2016-2021)
11.6.5 Teva Recent Development
11.7 Zeria（Tillotts）
11.7.1 Zeria（Tillotts） Company Details
11.7.2 Zeria（Tillotts） Business Overview
11.7.3 Zeria（Tillotts） Gastrointestinal Introduction
11.7.4 Zeria（Tillotts） Revenue in Gastrointestinal Business (2016-2021)
11.7.5 Zeria（Tillotts） Recent Development
11.8 Perrigo
11.8.1 Perrigo Company Details
11.8.2 Perrigo Business Overview
11.8.3 Perrigo Gastrointestinal Introduction
11.8.4 Perrigo Revenue in Gastrointestinal Business (2016-2021)
11.8.5 Perrigo Recent Development
11.9 Boehringer Ingelheim
11.9.1 Boehringer Ingelheim Company Details
11.9.2 Boehringer Ingelheim Business Overview
11.9.3 Boehringer Ingelheim Gastrointestinal Introduction
11.9.4 Boehringer Ingelheim Revenue in Gastrointestinal Business (2016-2021)
11.9.5 Boehringer Ingelheim Recent Development
11.10 Purdue Pharma
11.10.1 Purdue Pharma Company Details
11.10.2 Purdue Pharma Business Overview
11.10.3 Purdue Pharma Gastrointestinal Introduction
11.10.4 Purdue Pharma Revenue in Gastrointestinal Business (2016-2021)
11.10.5 Purdue Pharma Recent Development
11.11 C.B. Fleet
11.11.1 C.B. Fleet Company Details
11.11.2 C.B. Fleet Business Overview
11.11.3 C.B. Fleet Gastrointestinal Introduction
11.11.4 C.B. Fleet Revenue in Gastrointestinal Business (2016-2021)
11.11.5 C.B. Fleet Recent Development
11.12 Abbott
11.12.1 Abbott Company Details
11.12.2 Abbott Business Overview
11.12.3 Abbott Gastrointestinal Introduction
11.12.4 Abbott Revenue in Gastrointestinal Business (2016-2021)
11.12.5 Abbott Recent Development
11.13 Jiangzhong
11.13.1 Jiangzhong Company Details
11.13.2 Jiangzhong Business Overview
11.13.3 Jiangzhong Gastrointestinal Introduction
11.13.4 Jiangzhong Revenue in Gastrointestinal Business (2016-2021)
11.13.5 Jiangzhong Recent Development
11.14 Xian-Janssen
11.14.1 Xian-Janssen Company Details
11.14.2 Xian-Janssen Business Overview
11.14.3 Xian-Janssen Gastrointestinal Introduction
11.14.4 Xian-Janssen Revenue in Gastrointestinal Business (2016-2021)
11.14.5 Xian-Janssen Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Gastrointestinal Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Prescription Gastrointestinal Drug
Table 3. Key Players of OTC Gastrointestinal Drug
Table 4. Global Gastrointestinal Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Gastrointestinal Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Gastrointestinal Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Gastrointestinal Market Share by Regions (2016-2021)
Table 8. Global Gastrointestinal Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Gastrointestinal Market Share by Regions (2022-2027)
Table 10. Gastrointestinal Market Trends
Table 11. Gastrointestinal Market Drivers
Table 12. Gastrointestinal Market Challenges
Table 13. Gastrointestinal Market Restraints
Table 14. Global Gastrointestinal Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Gastrointestinal Market Share by Players (2016-2021)
Table 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal as of 2020)
Table 17. Ranking of Global Top Gastrointestinal Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Gastrointestinal Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gastrointestinal Product Solution and Service
Table 21. Date of Enter into Gastrointestinal Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gastrointestinal Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Gastrointestinal Revenue Market Share by Type (2016-2021)
Table 25. Global Gastrointestinal Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Gastrointestinal Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Gastrointestinal Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Gastrointestinal Revenue Market Share by Application (2016-2021)
Table 29. Global Gastrointestinal Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Gastrointestinal Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Gastrointestinal Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Gastrointestinal Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Gastrointestinal Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Gastrointestinal Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Gastrointestinal Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Gastrointestinal Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Gastrointestinal Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Gastrointestinal Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Gastrointestinal Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Gastrointestinal Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Gastrointestinal Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Gastrointestinal Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Gastrointestinal Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Gastrointestinal Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Gastrointestinal Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Gastrointestinal Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Gastrointestinal Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Gastrointestinal Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Gastrointestinal Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Gastrointestinal Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Gastrointestinal Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Gastrointestinal Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Gastrointestinal Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Gastrointestinal Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Gastrointestinal Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Gastrointestinal Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Gastrointestinal Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Gastrointestinal Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Gastrointestinal Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Gastrointestinal Market Size by Country (2022-2027) & (US$ Million)
Table 61. AstraZenec Company Details
Table 62. AstraZenec Business Overview
Table 63. AstraZenec Gastrointestinal Product
Table 64. AstraZenec Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 65. AstraZenec Recent Development
Table 66. Sanofi Company Details
Table 67. Sanofi Business Overview
Table 68. Sanofi Gastrointestinal Product
Table 69. Sanofi Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 70. Sanofi Recent Development
Table 71. Bayer Company Details
Table 72. Bayer Business Overview
Table 73. Bayer Gastrointestinal Product
Table 74. Bayer Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 75. Bayer Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Gastrointestinal Product
Table 79. Pfizer Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Gastrointestinal Product
Table 84. GlaxoSmithKline Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Teva Company Details
Table 87. Teva Business Overview
Table 88. Teva Gastrointestinal Product
Table 89. Teva Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 90. Teva Recent Development
Table 91. Zeria（Tillotts） Company Details
Table 92. Zeria（Tillotts） Business Overview
Table 93. Zeria（Tillotts） Gastrointestinal Product
Table 94. Zeria（Tillotts） Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 95. Zeria（Tillotts） Recent Development
Table 96. Perrigo Company Details
Table 97. Perrigo Business Overview
Table 98. Perrigo Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 99. Perrigo Recent Development
Table 100. Boehringer Ingelheim Company Details
Table 101. Boehringer Ingelheim Business Overview
Table 102. Boehringer Ingelheim Gastrointestinal Product
Table 103. Boehringer Ingelheim Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 104. Boehringer Ingelheim Recent Development
Table 105. Purdue Pharma Company Details
Table 106. Purdue Pharma Business Overview
Table 107. Purdue Pharma Gastrointestinal Product
Table 108. Purdue Pharma Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 109. Purdue Pharma Recent Development
Table 110. C.B. Fleet Company Details
Table 111. C.B. Fleet Business Overview
Table 112. C.B. Fleet Gastrointestinal Product
Table 113. C.B. Fleet Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 114. C.B. Fleet Recent Development
Table 115. Abbott Company Details
Table 116. Abbott Business Overview
Table 117. Abbott Gastrointestinal Product
Table 118. Abbott Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 119. Abbott Recent Development
Table 120. Jiangzhong Company Details
Table 121. Jiangzhong Business Overview
Table 122. Jiangzhong Gastrointestinal Product
Table 123. Jiangzhong Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 124. Jiangzhong Recent Development
Table 125. Xian-Janssen Company Details
Table 126. Xian-Janssen Business Overview
Table 127. Xian-Janssen Gastrointestinal Product
Table 128. Xian-Janssen Revenue in Gastrointestinal Business (2016-2021) & (US$ Million)
Table 129. Xian-Janssen Recent Development
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gastrointestinal Market Share by Type: 2020 VS 2027
Figure 2. Prescription Gastrointestinal Drug Features
Figure 3. OTC Gastrointestinal Drug Features
Figure 4. Global Gastrointestinal Market Share by Application: 2020 VS 2027
Figure 5. Chronic Gastritis Case Studies
Figure 6. Functional Dyspepsia Case Studies
Figure 7. Peptic Ulcer Case Studies
Figure 8. Acute Gastroenteritis Case Studies
Figure 9. Others Case Studies
Figure 10. Gastrointestinal Report Years Considered
Figure 11. Global Gastrointestinal Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Gastrointestinal Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Gastrointestinal Market Share by Regions: 2020 VS 2027
Figure 14. Global Gastrointestinal Market Share by Regions (2022-2027)
Figure 15. Global Gastrointestinal Market Share by Players in 2020
Figure 16. Global Top Gastrointestinal Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gastrointestinal as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Gastrointestinal Revenue in 2020
Figure 18. Global Gastrointestinal Revenue Market Share by Type (2016-2021)
Figure 19. Global Gastrointestinal Revenue Market Share by Type (2022-2027)
Figure 20. North America Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Gastrointestinal Market Share by Type (2016-2027)
Figure 22. North America Gastrointestinal Market Share by Application (2016-2027)
Figure 23. North America Gastrointestinal Market Share by Country (2016-2027)
Figure 24. United States Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Gastrointestinal Market Share by Type (2016-2027)
Figure 28. Europe Gastrointestinal Market Share by Application (2016-2027)
Figure 29. Europe Gastrointestinal Market Share by Country (2016-2027)
Figure 30. Germany Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Gastrointestinal Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Gastrointestinal Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Gastrointestinal Market Share by Region (2016-2027)
Figure 40. China Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Gastrointestinal Market Share by Type (2016-2027)
Figure 48. Latin America Gastrointestinal Market Share by Application (2016-2027)
Figure 49. Latin America Gastrointestinal Market Share by Country (2016-2027)
Figure 50. Mexico Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Gastrointestinal Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Gastrointestinal Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Gastrointestinal Market Share by Country (2016-2027)
Figure 56. Turkey Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Gastrointestinal Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZenec Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 60. Sanofi Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 61. Bayer Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 63. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 64. Teva Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 65. Zeria（Tillotts） Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 66. Perrigo Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 68. Purdue Pharma Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 69. C.B. Fleet Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 70. Abbott Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 71. Jiangzhong Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 72. Xian-Janssen Revenue Growth Rate in Gastrointestinal Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の胃腸用装置市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Gastrointestinal Devices Market The global Gastrointestinal Devices market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the …- 世界の消化管間質腫瘍市場規模・現状・予測（2021年-2027年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 世界の胃腸治療・診断市場 2021：企業別、地域別、種類・用途別 The Gastrointestinal Therapeutics and Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年） Gastrointestinal disorders refer to diseases involving the gastrointestinal tract, namely the esophagus, stomach, small intestine, large intestine and rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas. Market Analysis and Insights: Global Peptide Based Gastrointesti…
- 世界の胃腸障害治療市場規模・現状・予測（2021年-2027年） Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases. Increasing incidences…